The International Society of Cell & Gene Therapy (ISCT) Annual Meeting gathers various stakeholders that share a vision of the future in human medicine in which cell and gene therapies will add to the portfolio of potentially curative therapies. This year’s theme is Accelerate Cell and Gene Therapy Adoption: From Proof of Concept to Standard of Care.
Eric Faulkner, Vice President, Precision and Transformative Medicine, will be presenting as part of a larger virtual panel entitled, “Strategies for Commercialization,” on Session 7: Fast Track Regulations. This session will focus on both the opportunities and challenges presented with fast track regulatory pathways that are intended to accelerate the commercialization of cell and gene therapies.
Eric will also present an Elevator Pitch and a Poster Presentation at ISCT. The topic is “Shifting Clinical Trial and Value Demonstration Models for Cell and Gene Therapies: Present & Future Critical Success Factors.”